Repeatability of Cerebral Perfusion Using Dynamic Susceptibility Contrast MRI in Glioblastoma Patients12

correspondence to: Kourosh Jafari-Khouzani, PhD, Athinoula A. Martinos Biomedical Imaging, Department of Radiology, Massachusetts General 49 Thirteenth Street, Suite 2301, Charlestown, MA 02129, USA. [email protected] rk was supported by NCI/NIH R21CA117079, R01CA129371, and 440 (T.B.); NIH S10RR023401, 5R01NS069696, and 5R01NS060918 aic-Frederick Inc. grant 26XS263 (T.B.); Norwegian Research Council grant 0 and Norwegian Cancer Society Grant 3434180 (K.E.E.); Harvard Catalyst -RR-01066 (T.B.); and NIH Awards UL1 RR025758 (T.B. and B.R.) and 775 (O.W.); Harvard Catalyst | The Harvard Clinical and Translational Science tional Center for Research Resources and the National Center for Advancing al Sciences, NIH Award UL1 TR001102) and financial contributions from niversity and its affiliated academic healthcare centers. This work also involved the umentation supported by the NCRR Shared Instrumentation Grant Program 3401 and 1S10RR023043). Disclosure/conflict of interest: K.E.E. and A.B. ectual property rights at NordicNeuroLab AS. A.B. is a board member at roLab. K.S. is a co-founder of Imaging Biometrics LLC, a company that Kourosh Jafari-Khouzani, Kyrre E. Emblem, Jayashree Kalpathy-Cramer, Atle Bjørnerud , , Mark G. Vangel, Elizabeth R. Gerstner, Kathleen M. Schmainda, Kamran Paynabar, Ona Wu, Patrick Y. Wen, Tracy Batchelor, Bruce Rosen and Steven M. Stufflebeam